ID   TX-LY-172h
AC   CVCL_AQ50
DR   Wikidata; Q54973434
RX   PubMed=26080839;
RX   PubMed=28119491;
CC   From: Texas Cancer Cell Repository (TXCCR); Lubbock; USA.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   8Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 02-05-24; Version: 6
//
RX   PubMed=26080839; DOI=10.1158/1078-0432.CCR-15-0114; PMCID=PMC4681691;
RA   Hall C.P., Reynolds C.P., Kang M.H.;
RT   "Modulation of glucocorticoid resistance in pediatric T-cell acute
RT   lymphoblastic leukemia by increasing BIM expression with the PI3K/mTOR
RT   inhibitor BEZ235.";
RL   Clin. Cancer Res. 22:621-632(2016).
//
RX   PubMed=28119491; DOI=10.1158/1535-7163.MCT-16-0749;
RA   Makena M.R., Koneru B., Nguyen T.H., Kang M.H., Reynolds C.P.;
RT   "Reactive oxygen species-mediated synergism of fenretinide and
RT   romidepsin in preclinical models of T-cell lymphoid malignancies.";
RL   Mol. Cancer Ther. 16:649-661(2017).
//